Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities. | Genes Dis | 2024 | 37692481 | PubTator, text mining | PubMed |
| A narrative review of the role of Eph receptors in head and neck squamous cell carcinoma. | Oral Dis | 2024 | 37279081 | PubTator, text mining | PubMed |
| An investigation of binding interactions of tumor-targeted peptide conjugated polyphenols with the kinase domain of ephrin B4 and B2 receptors. | Mol Divers | 2024 | 36847923 | PubTator, text mining | PubMed |
| Insight into Steroid-Induced ONFH: The Molecular Mechanism and Function of Epigenetic Modification in Mesenchymal Stem Cells. | Biomolecules | 2023 | 38275745 | PubTator, text mining | PubMed |
| Current perspectives and trends in the treatment of brain arteriovenous malformations: a review and bibliometric analysis. | Front Neurol | 2023 | 38274874 | PubTator, text mining | PubMed |
| Autocrine IGF-II-Associated Cancers: From a Rare Paraneoplastic Event to a Hallmark in Malignancy. | Biomedicines | 2023 | 38255147 | PubTator, text mining | PubMed |
| Effects of Aging on Osteosynthesis at Bone-Implant Interfaces. | Biomolecules | 2023 | 38254652 | PubTator, text mining | PubMed |
| Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction. | J Clin Med | 2023 | 38202257 | PubTator, text mining | PubMed |
| Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy. | Front Immunol | 2023 | 38193080 | PubTator, text mining | PubMed |
| Single-cell analysis identifies phospholysine phosphohistidine inorganic pyrophosphate phosphatase as a target in ulcerative colitis. | World J Gastroenterol | 2023 | 38186864 | PubTator, text mining | PubMed |
Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell Pathophysiology. | Cell Mol Neurobiol | 2023 | 38150042 | PubTator, text mining | PubMed |
| Homeostatic Regulation of Pro-Angiogenic and Anti-Angiogenic Proteins via Hedgehog, Notch Grid, and Ephrin Signaling in Tibial Dyschondroplasia. | Animals (Basel) | 2023 | 38136788 | PubTator, text mining | PubMed |
| Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression. | Signal Transduct Target Ther | 2023 | 38097539 | PubTator, text mining | PubMed |
| Machine learning algorithm integrates bulk and single-cell transcriptome sequencing to reveal immune-related personalized therapy prediction features for pancreatic cancer. | Aging (Albany NY) | 2023 | 38095640 | PubTator, text mining | PubMed |
| Iodine catalyzed synthesis of imidazo[1,2-a]pyrazine and imidazo[1,2-a]pyridine derivatives and their anticancer activity. | RSC Adv | 2023 | 38093732 | PubTator, text mining | PubMed |
| The effects of semaphorin 3A in bone and cartilage metabolism: fundamental mechanism and clinical potential. | Front Cell Dev Biol | 2023 | 38078001 | PubTator, text mining | PubMed |
| Receptor tyrosine kinases: biological functions and anticancer targeted therapy. | MedComm (2020) | 2023 | 38077251 | PubTator, text mining | PubMed |
| Role of ADAM and ADAMTS proteases in pathological tissue remodeling. | Cell Death Discov | 2023 | 38071234 | PubTator, text mining | PubMed |
| Oral Pyogenic Granuloma: A Narrative Review. | Int J Mol Sci | 2023 | 38069207 | PubTator, text mining | PubMed |
| Editorial: Vein of galen malformation: a scientific and clinical journey targeting the best outcome. | Front Pediatr | 2023 | 38027306 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=9